Skip to main content

Timothy M Fan

Assistant Head, Research & Graduate Studies, Veterinary Clinical Medicine

Additional Campus Affiliations

Assistant Head, Research & Graduate Studies, Veterinary Clinical Medicine
Director, Veterinary Clinical Trials Center, Veterinary Clinical Medicine
Professor, Veterinary Clinical Medicine
Professor, Veterinary Teaching Hospital
Professor, Pathobiology
Professor, Biomedical and Translational Sciences
Professor, Carl R. Woese Institute for Genomic Biology
Associate Director for Development and Translation, Cancer Center at Illinois, Office of the Vice Chancellor for Research and Innovation
Program Leader, Cancer Center at Illinois, Office of the Vice Chancellor for Research and Innovation
Adjunct Professor, Comparative Biosciences

Recent Publications

Bentley, R. T., Fan, T. M., & Lowrie, M. (2023). Editorial: Chemotherapy and other pharmacotherapies for canine neurological disorders. Frontiers in Veterinary Science, 10, Article 1323496. https://doi.org/10.3389/fvets.2023.1323496

Boudreau, M. W., Tonogai, E. J., Schane, C. P., Xi, M. X., Fischer, J. H., Vijayakumar, J., Ji, Y., Tarasow, T. M., Fan, T. M., Hergenrother, P. J., & Dudek, A. Z. (2023). The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma. Melanoma research, 33(6), 514-524. https://doi.org/10.1097/CMR.0000000000000927

Danciu, O. C., Holdhoff, M., Peterson, R. A., Fischer, J. H., Liu, L. C., Wang, H., Venepalli, N. K., Chowdhery, R., Nicholas, M. K., Russell, M. J., Fan, T. M., Hergenrother, P. J., Tarasow, T. M., & Dudek, A. Z. (2023). Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. British Journal of Cancer, 128(5), 783-792. https://doi.org/10.1038/s41416-022-02089-7

Gordon, D. L., Foreman, J. H., Connolly, S. L., Schnelle, A. N., Fan, T. M., & Barger, A. M. (2023). Acute phase protein concentrations following serial procaine penicillin G injections in horses. Equine veterinary journal, 55(5), 916-922. https://doi.org/10.1111/evj.13886

Hergenrother, P. J., Botham, R. C., Fan, T. M., Gilbert, M. J., Handley, M. K., Roth, H. S., & Tarasow, T. (2023). Procaspase 3 Activation By Combination Therapy. (U.S. Patent No. 11833147).

View all publications on Illinois Experts

In the news

  • The SHIELD: Target, Test, Tell program combined frequent saliva tests with modeling and an app to keep the University of Illinois Urbana-Champaign campus and surrounding community safe when on-campus operations resumed in fall 2020.
  • A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels.